持田製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/11/20 | 4,080 | 4,120 | 4,050 | 4,090 | -15 | -0.4% | 36,100 |
2020/11/19 | 4,145 | 4,145 | 4,065 | 4,105 | -65 | -1.6% | 45,500 |
2020/11/18 | 4,115 | 4,175 | 4,085 | 4,170 | +35 | +0.8% | 35,400 |
2020/11/17 | 4,150 | 4,150 | 4,085 | 4,135 | -15 | -0.4% | 43,900 |
2020/11/16 | 4,135 | 4,190 | 4,110 | 4,150 | +85 | +2.1% | 51,800 |
2020/11/13 | 4,160 | 4,160 | 4,005 | 4,065 | -60 | -1.5% | 46,500 |
2020/11/12 | 4,115 | 4,145 | 4,065 | 4,125 | +10 | +0.2% | 36,400 |
2020/11/11 | 4,220 | 4,240 | 4,070 | 4,115 | -40 | -1% | 69,100 |
2020/11/10 | 4,160 | 4,195 | 4,105 | 4,155 | +40 | +1% | 70,600 |
2020/11/09 | 4,160 | 4,160 | 4,060 | 4,115 | -15 | -0.4% | 54,200 |
2020/11/06 | 4,080 | 4,160 | 4,050 | 4,130 | +20 | +0.5% | 54,400 |
2020/11/05 | 3,995 | 4,125 | 3,995 | 4,110 | +145 | +3.7% | 61,400 |
2020/11/04 | 3,940 | 4,035 | 3,935 | 3,965 | +60 | +1.5% | 89,700 |
2020/11/02 | 3,850 | 3,935 | 3,805 | 3,905 | +105 | +2.8% | 77,600 |
2020/10/30 | 3,850 | 3,850 | 3,770 | 3,800 | -80 | -2.1% | 39,400 |
2020/10/29 | 3,890 | 3,940 | 3,880 | 3,880 | -10 | -0.3% | 33,800 |
2020/10/28 | 3,835 | 3,910 | 3,810 | 3,890 | +20 | +0.5% | 34,600 |
2020/10/27 | 3,835 | 3,885 | 3,815 | 3,870 | +15 | +0.4% | 38,100 |
2020/10/26 | 3,850 | 3,940 | 3,830 | 3,855 | +5 | +0.1% | 46,100 |
2020/10/23 | 3,830 | 3,895 | 3,810 | 3,850 | +20 | +0.5% | 31,000 |
2020/10/22 | 3,865 | 3,870 | 3,800 | 3,830 | -70 | -1.8% | 33,400 |
2020/10/21 | 3,885 | 3,960 | 3,885 | 3,900 | +45 | +1.2% | 23,800 |
2020/10/20 | 3,910 | 3,915 | 3,850 | 3,855 | -80 | -2% | 28,600 |
2020/10/19 | 3,860 | 3,945 | 3,835 | 3,935 | +55 | +1.4% | 24,800 |
2020/10/16 | 3,925 | 3,925 | 3,865 | 3,880 | -40 | -1% | 20,700 |
2020/10/15 | 3,975 | 3,990 | 3,910 | 3,920 | -95 | -2.4% | 21,400 |
2020/10/14 | 4,060 | 4,095 | 4,015 | 4,015 | -50 | -1.2% | 27,400 |
2020/10/13 | 4,080 | 4,080 | 4,060 | 4,065 | -10 | -0.2% | 26,300 |
2020/10/12 | 4,050 | 4,095 | 4,050 | 4,075 | +5 | +0.1% | 17,700 |
2020/10/09 | 4,170 | 4,170 | 4,045 | 4,070 | -85 | -2% | 37,100 |
2020/10/08 | 4,105 | 4,175 | 4,080 | 4,155 | +75 | +1.8% | 37,400 |
2020/10/07 | 4,175 | 4,185 | 4,075 | 4,080 | -80 | -1.9% | 33,700 |
2020/10/06 | 4,150 | 4,185 | 4,090 | 4,160 | +10 | +0.2% | 30,100 |
2020/10/05 | 4,225 | 4,285 | 4,125 | 4,150 | -35 | -0.8% | 39,700 |
2020/10/02 | 4,255 | 4,300 | 4,165 | 4,185 | - | - | 78,200 |
2020/10/01 | 0 | 0 | 0 | 0 | - | - | 0 |
2020/09/30 | 4,250 | 4,290 | 4,155 | 4,155 | -80 | -1.9% | 45,700 |
2020/09/29 | 4,260 | 4,270 | 4,140 | 4,235 | -115 | -2.6% | 60,800 |
2020/09/28 | 4,200 | 4,370 | 4,195 | 4,350 | +245 | +6% | 85,700 |
2020/09/25 | 4,095 | 4,180 | 4,095 | 4,105 | +20 | +0.5% | 58,600 |
2020/09/24 | 4,045 | 4,125 | 4,045 | 4,085 | +60 | +1.5% | 42,100 |
2020/09/23 | 4,015 | 4,045 | 3,945 | 4,025 | -40 | -1% | 49,500 |
2020/09/18 | 4,005 | 4,085 | 4,000 | 4,065 | +60 | +1.5% | 60,800 |
2020/09/17 | 4,005 | 4,050 | 3,980 | 4,005 | ±0 | ±0% | 38,500 |
2020/09/16 | 4,020 | 4,025 | 3,975 | 4,005 | +40 | +1% | 29,500 |
2020/09/15 | 4,005 | 4,005 | 3,935 | 3,965 | -45 | -1.1% | 16,500 |
2020/09/14 | 3,995 | 4,040 | 3,950 | 4,010 | +50 | +1.3% | 34,400 |
2020/09/11 | 3,915 | 3,965 | 3,890 | 3,960 | +20 | +0.5% | 40,600 |
2020/09/10 | 3,895 | 3,970 | 3,895 | 3,940 | +55 | +1.4% | 34,600 |
2020/09/09 | 3,820 | 3,915 | 3,820 | 3,885 | -30 | -0.8% | 49,000 |
1101~
1150
件表示中 / 3705件
類似銘柄と比較する
現在ご覧いただいている「持田薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
持田薬 | 297,600円 | +5.1% | -7.0% | 2.69% | 19.54倍 | 0.81倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
ジーエヌアイ | 297,100円 | +21.7% | +999.9% | 0.00% | 12.45倍 | 4.12倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
ゼリア新薬 | 213,700円 | +3.1% | -6.5% | 2.25% | 9.92倍 | 1.05倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
杏林製薬 | 146,000円 | -2.4% | -52.3% | 3.90% | 17.47倍 | 0.62倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
栄研化 | 200,000円 | +4.1% | -3.1% | 2.90% | 17.54倍 | 1.53倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム